Cardio Diagnostics Holdings, Inc.
CDIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $3 | $7 | $1 | $5 |
| % Growth | -61.8% | 695.2% | -79.2% | – |
| Cost of Goods Sold | $90 | $89 | $0 | $0 |
| Gross Profit | -$87 | -$82 | $1 | $5 |
| % Margin | -3,037.9% | -1,092.5% | 100% | 100% |
| R&D Expenses | $189 | $7 | $2 | $6 |
| G&A Expenses | $0 | $0 | $1,542 | $1,472 |
| SG&A Expenses | $1,436 | $1,590 | $1,584 | $1,510 |
| Sales & Mktg Exp. | $0 | $0 | $42 | $38 |
| Other Operating Expenses | $0 | $0 | $45 | $5 |
| Operating Expenses | $1,625 | $1,597 | $1,632 | $1,521 |
| Operating Income | -$1,712 | -$1,679 | -$1,631 | -$1,516 |
| % Margin | -59,950.9% | -22,457.5% | -173,463.8% | -33,608.2% |
| Other Income/Exp. Net | -$3 | -$5 | -$5 | -$3 |
| Pre-Tax Income | -$1,715 | -$1,683 | -$1,635 | -$1,519 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,715 | -$1,683 | -$1,635 | -$1,519 |
| % Margin | -60,053.8% | -22,517.7% | -173,943% | -33,672.6% |
| EPS | -0.98 | -0.97 | -0.97 | -0.062 |
| % Growth | -1% | 0% | -1,459.5% | – |
| EPS Diluted | -0.98 | -0.97 | -0.97 | -0.062 |
| Weighted Avg Shares Out | 1,758 | 1,739 | 1,686 | 45,944 |
| Weighted Avg Shares Out Dil | 1,758 | 1,739 | 1,686 | 45,944 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3 | $5 | $5 | $3 |
| Depreciation & Amortization | $90 | $89 | $125 | $84 |
| EBITDA | -$1,622 | -$1,589 | -$1,505 | -$1,432 |
| % Margin | -56,806.3% | -21,262.4% | -160,112% | -31,733.4% |